Calendar Valneva

Equities

VLA

FR0004056851

Market Closed - Euronext Paris 16:35:14 26/04/2024 BST 5-day change 1st Jan Change
3.444 EUR -0.06% Intraday chart for Valneva -5.95% -27.03%

Chart calendar Valneva

b54db.5GYqcaxucym7zJ2z_wj9tBqe7Jr0qzFfKo2ZBhxN_9M.hwVORfY0Slr2ocX_r0ec517oiNnEn0AAcrnednE8h-SzHFAH1iw1Tt2A9g~6855b98e39d61cc1f1f8acf53a82d388

Upcoming events on Valneva

07/05/2024 06:00 Q1 2024 Earnings Release
25/06/2024 Annual General Meeting
13/08/2024 06:00 Q2 2024 Earnings Release
07/11/2024 06:00 Q3 2024 Earnings Release
19/03/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)
11/08/2025 Q2 2025 Earnings Release (Projected)
05/11/2025 Q3 2025 Earnings Release (Projected)

Past events on Valneva

15/04/2024 Van Lanschot Kempen Life Sciences Conference
31/03/2024 World Vaccine Congress
20/03/2024 14:00 Q4 2023 Earnings Call
20/03/2024 06:00 Q4 2023 Earnings Release
03/03/2024 TD Cowen Health Care Conference
15/02/2024 06:00 Q4 2023 Sales and Revenue Release
07/02/2024 15:30 Guggenheim Healthcare Talks Biotechnology Conference
14/01/2024 Oddo BHF Forum
07/01/2024 JPMorgan Healthcare Conference
20/12/2023 13:00 Extraordinary Shareholders Meeting
14/11/2023 14:30 Jefferies London Healthcare Conference
13/11/2023 14:00 IXCHIQ FDA Approval Call
11/11/2023 International Society for Pharmacoeconomics and Outcomes Research European Congress
09/11/2023 14:00 Q3 2023 Earnings Call
09/11/2023 06:00 Q3 2023 Earnings Release
24/10/2023 08:45 International Society of Vaccines Congress
20/10/2023 18:15 American Society of Tropical Medicine and Hygiene Meeting
20/10/2023 17:00 American Society of Tropical Medicine and Hygiene Meeting
15/10/2023 World Vaccine Congress
15/10/2023 World Vaccine Congress

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
126
124
1.84%
110
121
-8.96%
348
103
237.38%
361
342
5.67%
154
168
-8.63%

192

EBITDA
Million EUR
Released
Forecast
Spread
7,80
10,6
-26.16%
-45,2
-42,9
-5.26%
-47,1
-31,6
-48.94%
-69,2
-30,3
-128.36%
-65,2
-65,1
-0.21%

53,8

EBIT
Million EUR
Released
Forecast
Spread
-0,81
1,73
-146.99%
-55,1
-52,7
-4.61%
-61,4
-63,7
3.55%
-113
-33,8
-235.21%
-82,1
-58,3
-40.89%

31,7

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-0,87
-3,96
78.01%
-65,3
-64,1
-1.95%
-70,0
55,6
-225.97%
-145
-84,4
-71.58%
-98,6
-91,3
-7.99%

22,7

Net income
Million EUR
Released
Forecast
Spread
-1,70
-4,87
65.1%
-64,4
-62,7
-2.74%
-73,4
-64,3
-14.14%
-143
-85,4
-67.77%
-101
-90,8
-11.69%

25,4

EPS
EUR
Released
Forecast
Spread
-0,02
-0,05
56.1%
-0,71
-0,69
-3.5%
-0,75
-0,61
-22.95%
-1,24
-0,59
-110.17%
-0,73
-0,52
-41.42%

0,15

Announcement Date27/02/2025/02/2103/02/2223/03/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million EUR
Released
Forecast
Spread
47,9
72,5
-33.92%
278
26,9
934.85%
21,8
22,6
-3.57%
71,4
21,4
232.96%
93,2
45,3
105.69%
157
116
34.81%
111
90,0
23.73%
33,5
30,4
10.29%
40,2
33,1
21.5%
38,1
41,4
-8.06%
41,9
83,4
-49.74%

66,6


38,0


43,2


52,2

EBITDA
Million EUR
Released
Forecast
Spread



12,5
-31,8
139.43%
-13,3
-48,7
72.69%
-123
-43,0
-185.35%




-5,20




























EBIT
Million EUR
Released
Forecast
Spread
-21,9
-9,20
-138.35%
11,1
-37,2
129.87%
-18,4
-69,6
73.56%
-129
-45,2
-185.02%
-147
-98,9
-48.8%
93,3
36,2
158.09%
-56,4
34,9
-261.4%
-16,6
-21,5
22.8%
-20,3
-18,4
-9.98%
-22,2
-22,5
1.16%
-24,9
24,5
-201.85%

77,4


-20,0


-16,0


-15,6

EPS
EUR
Released
Forecast
Spread





















-0,13
-0,14
7.14%
-0,12
-0,13
7.69%
-0,25
-0,12
-108.33%
-0,23
-0,14
-64.29%

0,60


-0,09


-0,12


-0,11

Announcement Date04/08/2003/02/2205/05/2211/08/2211/08/2210/11/2223/03/2304/05/2321/09/2309/11/2321/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise